Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Jill E. Feldman"'
Publikováno v:
American Society of Clinical Oncology Educational Book. :116-126
Rapid advancements in cancer discovery, diagnosis, and treatment options available to patients with cancer have highlighted the need for enhancements in clinical trial design. The drug development process is costly, with more than 80% of trials faili
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f0c810852ccf61577a320c98335faa76
https://doi.org/10.1200/edbk_350574
https://doi.org/10.1200/edbk_350574
Autor:
Laura A. Petrillo, Sophia E. Shimer, Ashley Z. Zhou, Robert K. Sommer, Jill E. Feldman, Kelly E. Hsu, Joseph A. Greer, Lara N. Traeger, Jennifer S. Temel
Publikováno v:
CancerREFERENCES. 128(16)
Although most patients with cancer prefer to know their prognosis, prognostic communication between oncologists and patients is often insufficient. Targeted therapies for lung cancer improve survival yet are not curative and produce variable response
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21748bc21dd957d768d836645a6db2c4
https://pubmed.ncbi.nlm.nih.gov/35731234
https://pubmed.ncbi.nlm.nih.gov/35731234
Autor:
Joan B. Fowler, Jill E. Feldman, Lecia V. Sequist, Rebecca Weaver, Tina Trieu, Ivy Beth Elkins
Publikováno v:
Journal of Clinical Oncology. 40:e23010-e23010
e23010 Background: Recognizing the growing need to support early-career scientists, the EGFR Resisters Research Summit (EGFRRS) strives to identify, cultivate, and prepare young investigators (YIs) for successful careers that advance the field of EGF
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bef5930bcc410b2a0b2824ebfc5c2a07
https://doi.org/10.1200/jco.2022.40.16_suppl.e23010
https://doi.org/10.1200/jco.2022.40.16_suppl.e23010